Peer-reviewedCC BY-NC 4.0Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Disease Stage and Efficacy Interpretation in Gene Therapy for Arrhythmogenic Cardiomyopathy
- 1Department of Molecular Medicine University of Pavia Pavia Italy
- 2Department of Cardiology IRCCS ICS Maugeri Pavia Italy
Related
- Case Report: Suspected biventricular arrhythmogenic cardiomyopathy presenting as a dilated cardiomyopathy-like phenotype with multimodal phenotyping and cautious genetic interpretation
- Phenotypic Transition From Danon Disease to Arrhythmogenic Cardiomyopathy
- Elimination of Epicardial Late Potentials by Endocardial Ablation in Arrhythmogenic Right Ventricular Cardiomyopathy
- Incremental prognostic value of hepatic tissue alterations derived from cardiac magnetic resonance imaging for arrhythmogenic right ventricular cardiomyopathy: a case-control study
- Risk Stratification and Outcomes of Right Atrial Phasic Function in Arrhythmogenic Right Ventricular Cardiomyopathy: A Cardiac Magnetic Resonance Study
BibTeX
@article{mazzanti2026disease,
title = {{Disease Stage and Efficacy Interpretation in Gene Therapy for Arrhythmogenic Cardiomyopathy}},
author = {Andrea Mazzanti},
journal = {Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease},
year = {2026},
month = sep,
doi = {10.1161/jaha.126.052865},
url = {https://doi.org/10.1161/jaha.126.052865},
note = {CC BY-NC 4.0},
}
RIS
TY - JOUR
TI - Disease Stage and Efficacy Interpretation in Gene Therapy for Arrhythmogenic Cardiomyopathy
AU - Andrea Mazzanti
PY - 2026
DA - 2026/09/09
JO - Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
DO - 10.1161/jaha.126.052865
UR - https://doi.org/10.1161/jaha.126.052865
SN - 2047-9980
ER -